Risks tied to this specific entity.
No issues detected across 7 sources
No issues detected across 1 source
Lonza Group's divestiture of its Personalized Medicine Business to Octane Medical Group presents supply chain and operational continuity risks requiring monitoring.
Lonza Group's divestiture of its Personalized Medicine Business to Octane Medical Group presents high supply chain risk due to potential operational disruption, customer continuity concerns, and transition management complexities.
Lonza warns that major pharmaceutical companies may postpone outsourcing decisions due to competing U.S. manufacturing investments, creating potential near-term revenue uncertainty for the CDMO.
marketscreener.com: Lonza Says Big Pharma Might Delay Outsourcing Decisions A...; hea.china.com: MAG菲速关节生 , 引入瑞士龙沙专利UC - II® , 专业守护宠物关节健康 _ 中华网; indiaeducationdiary.in: Lonza Selects Hyderabad as new GCC location , Reinforcing...
GDELTNo issues detected across 2 sources
Top origins: Switzerland, Belgium, Germany. Period: 2023-05-01 to 2026-05-01
ImportYeti (US Customs)No issues detected across 1 source
No issues detected across 1 source
Risks tied to the location of this facility.
Political stability: 1.07, Rule of law: 1.76, Corruption control: 2.02
World Bank WGI 2023No issues detected across 2 sources
No issues detected across 3 sources